Nominees for the RCVS Council and its Veterinary Nurses Council have been announced, with 13 candidates for the former and four for the latter.
The nominations closed on 31 January, and the following are standing:
RCVS Council
* denotes current RCVS Council member
VN Council
* denotes current VN Council member
The RCVS has removed 333 veterinary surgeons from the Register for non-payment of their annual renewal fees.
The final deadline for payment of the annual renewal fee passed on 31 May and the RCVS has written to those who have not paid to inform them of their removal from the Register. In 2013, 369 veterinary surgeons were removed from the Register for non-payment.
A list of the veterinary surgeons who have been removed - and who have not been subsequently restored to the Register - has today been published on the RCVS website (www.rcvs.org.uk/vetremovals2014).
This list is published to alert those veterinary surgeons who have not responded to RCVS communications to check their registration status, and to remind employers to check the registration status of their employees. The registration status of any veterinary surgeon or veterinary nurse can also be checked online at www.rcvs.org.uk/check-the-register.
Any veterinary surgeon whose name appears on the list who believes they have paid their fee should contact the RCVS Finance Department as soon as possible on 020 7202 0723.
Veterinary surgeons and employers are reminded that, under the Veterinary Surgeons Act, it is illegal to allow anyone who is not on the RCVS Register to practise veterinary surgery. They can also no longer use the postnominal 'MRCVS' and any professional indemnity insurance the veterinary surgeon may have is also rendered invalid.
Further information about restoration to the Register, and a restoration application form, can be found at www.rcvs.org.uk/registration or by contacting the Registration Department on membership@rcvs.org.uk or 020 7202 0707.
In order to be restored to the Register, veterinary surgeons must pay a fee of at least £299, in addition to the outstanding annual renewal fee. The restoration fee increases each successive year a removed member remains off the Register.
The study was a randomised controlled trial of client-owned dogs and cats presenting as emergencies and requiring intravenous catheterisation.
Patient signalment and mentation score were recorded.
Patients were randomly allocated to either a swab saturated with vapocoolant spray or a swab saturated with saline applied to the clipped area before intravenous catheterisation.
Indirect application of vapocoolant spray via a swab before catheterisation was not found to significantly reduce the reaction of dogs and cats, nor to improve placement success rates.
The study did demonstrate a significantly greater adverse response to vapocoolant spray application to the skin via a swab when compared with the saline control in canine patients; feline patients demonstrated adverse responses to both vapocoolant spray and saline swabs.
It is unclear if the technique of application used in this study provided sufficient cooling effect to provide the required cryoanaesthesia to influence patient reaction.
The authors say future studies should be used to determine optimal vapocoolant spray application technique in dogs and cats, as well as examine its application in other populations and procedures.
Nicola Di Girolamo, Editor of JSAP concluded: “Pragmatic, adequately-powered, randomised controlled trials like the one presented here are essential to evaluate whether an intervention is not only efficacious in a controlled environment, but also effective during clinical practice.”
Full article: https://onlinelibrary.wiley.com/doi/full/10.1111/jsap.13504
Reference
Trinder, R, Humm, K, Phillips, S, and Cole, L (2022) The efficacy of vapocoolant spray for the improved tolerance of catheter pain in emergency patients in dogs Journal of Small Animal Practice, Available at: https://onlinelibrary.wiley.com/doi/full/10.1111/jsap.13504
DairyCo has announced the launch of a new programme designed to tackle the challenge of lameness on dairy farms.
The Healthy Feet Programme has been developed to provide a structured approach to assist vets and foot trimmers to work more closely with their farmer clients, to reduce the incidence of lameness on a permanent basis.
DairyCo product manager, Kate Cross said: "We've developed the programme to build on the DairyCo Mobility Score by introducing a programme that dairy farmers can undertake working with their vet who is a trained 'mobility mentor', to identify problems, risk factors and suitable intervention strategies on the farm. An action plan is then agreed to prioritise management practices that have a permanent impact on incidence of lameness."
The programme draws on the findings from the Bristol Healthy Feet Project, the New Zealand Healthy Hooves programme, First Steps and Claw Signals. As well as the valuable experience gained from the DairyCo mastitis plan. It has been designed to combine the best features of all these programmes and aims to build on the successful DairyCo Mobility Score.
Vets are invited to enrol for a two day CPD course, which will enable them to introduce the Healthy Feet Programme to their farmer clients and provide on-going support, assisted by a range of resources provided by DairyCo.
The first course is scheduled for June 2011
For further details please contact Kate Cross on 02476 478686 or email healthyfeet@dairyco.ahdb.org.uk
A new study1 lead by led by Dr Séverine Tasker at the University of Bristol's School of Veterinary Sciences and published in the journal Clinical and Vaccine Immunology (CVI), has shown that cats previously infected with the blood-borne bacteria M. haemofelis develop immunity from re-infection.
Haemoplasmas are a group of blood borne bacteria found in a wide range of mammals, including domestic and wild cats, and can cause severe anaemia. The findings of the new study have significantly advanced researchers' knowledge of immunity for these pathogens.
Information about the immune responses that occur in animals following haemoplasma infection is relatively unknown, largely due to the fact that researchers struggle to study these bacteria as they are unable to grow them in the laboratory. Antibiotics do not consistently clear infection and without correct treatment the anaemia can be fatal. Recently haemoplasma associated anaemia has been reported in a human too.
The aim of the study was to determine whether cats who had previously recovered from M. haemofelis infection were protected from re-infection. The researchers found that they were, representing a significant advancement in scientists' knowledge of immunity for haemoplasma infections.
The exact methods of protective immunity could not be clearly identified despite extensive investigations, but the study's results suggest that a vaccine, using a weakened form of the bacteria, may offer protection against haemoplasma infection.
Séverine said: "This is the first study to demonstrate protective immunity against M. haemofelis reinfection and it provides important information for a possible future haemoplasma vaccine.
"Our findings could help prevent the disease in cats and could also be of particular importance to farm animal species where haemoplasma infections can cause huge financial losses."
The study recommends future research should explore whether the bacterial animal infection could be transmitted to humans and how the immune system targets the pathogen.
The first course will be overseen by Jodie Hughes, an RCVS and European specialist in anaesthesia and analgesia. The hospital’s inaugural resident will be Luisa Oliveira (pictured right), who earlier completed a rotating internship at North West Veterinary Specialists in Cheshire, and, more recently, an anaesthesia-specific one at NDSR.
Jodie said: “Luisa’s residency will comprise mainly the provision of anaesthesia to multiple animal species, ranging from the ‘simpler’ procedures to the most critical and complex, which we frequently encounter in our interventional cardiac procedures and emergency work.
“A significant component of the training will involve the management of pain, both in the acute setting (in the peri-operative period) and in the chronic setting, whilst dealing with our pain clinic patients.
“Luisa will also be trained in the management of emergency and critical care patients and will undergo rotations in other services to better grasp their requirements.
“As we work exclusively with dogs and cats, we will work in close collaboration with several other hospitals in the UK and continental Europe, to complement Luisa’s training with other species.
“As part of this, Luisa will be exposed to multiple advanced techniques, including ultrasound-guided regional nerve blocks and interventional procedures in our pain clinic.
Luisa said: “This is a fantastic opportunity for me to work alongside an incredibly experienced and skilled team at NDSR.
The training programme has been developed by Rui Pinelas, RCVS and European specialist in anaesthesia and analgesia at NDSR, who is optimistic there will be further training opportunities in the near future.
Rui said: “This was something NDSR has been keen to implement for some time and we had been having ongoing discussions to choose the perfect time.
“In terms of logistics, it took around three months for us to set up this anaesthesia residency, which was largely spent organising our partnerships with the other training facilities and undergoing an evaluation as to whether our facilities and case load would meet the specialist board’s strict requirements, which we are delighted they did.”
The sessions will allow members of the profession to find out about upcoming College projects and put questions to the RCVS Officer Team, RCVS Council members and senior staff, in a friendly, informal atmosphere.
The first event is taking place at the Hilton Glasgow on William Street at 6:30pm, where there'll be supper and drinks before the main event at 7:30pm, when RCVS President Melissa Donald, RCVS Treasurer Niall Connell, RCVS Senior Vice-President Kate Richards, Junior Vice-President Sue Paterson, VN Council Chair Matthew Rendle, RCVS Registrar Eleanor Ferguson and RCVS CEO Lizzie Lockett will update everyone on College activities and take questions.
The College says that the topics for discussion will be up to the audience but are likely to include workforce issues, the review of RCVS guidance on under care, proposals for legislative reform, VetGDP and the future of extra-mural studies.
Melissa said: “In my opening speech as RCVS President I said that one of the key missions of my presidential year was to talk – and especially listen – to as many members of the professions as I possibly can.
“Relaunching our question time programme after a hiatus will give me the opportunity to do exactly this, as well as giving members of the professions that all-important opportunity to put their questions and concerns directly to us.
"We might not be able to address every problem, but these events give an excellent opportunity for vets and nurses to raise issues, forge connections with their peers and work together to find solutions.
“I hope that many of you will be able to come to our first in-person event in Glasgow but we will also be holding these question times virtually in the future for those people who may struggle to make it to these evening events.
"Rest assured – if you want to be heard, we will find a way to listen.”
The next in-person event is due to take place in Nottingham in January 2023 while the first virtual question time will take place in November 2022.
To register for the Glasgow event visit: tinyurl.com/22pem3d6
MI:RNA says that current testing practices for Johne’s disease mean that identification of the disease is difficult, with current sensitivities of around 10-40% and little to no ability to diagnose early stages of infection.
The loss of productivity due to Johne’s to the UK agricultural economy is estimated to be in excess of £10 million annually.
MI:RNA says it is the first diagnostic testing company to use microRNA assay technology.
MicroRNAs are newly discovered biomarkers that manage the immune system and immune responses and act as regulators for disease progression or resolution.
This, says the company, makes them excellent biomarkers of disease, and when combined AI, can significantly improve identification of Johne’s and other complex conditions, and predict disease outcomes.
MI:RNA says this development will allow veterinary surgeons, farmers and pet owners to test for a variety of conditions, not just Johne’s.
Target areas include heart and kidney disease, osteoarthritis and bovine tuberculosis, along with effective general wellness and preoperative screening.
Eve Hanks, founder and CEO of MI:RNA, said: “Increasing market and global pressures on bovine protein production means that animal health has never been more important.
"This is a key area of research and development for MI:RNA and biomarker science combined with our unique AI-powered modelling, means that we can significantly improve animal health and reduce greenhouse gas output.
“The breakthrough that we’ve already achieved in Johne’s testing is unparalleled, and has provided an opportunity for MI:RNA to pitch our business concept in the USA to the The Kansas City Animal Health Summit.
"Following our presentation, we have now progressed through to the final selection stage for European Innovation Council funding for our work on Johne’s disease.
“In terms of future applications, microRNAs can assist with vital drug discovery, progressing future diagnostic testing and understanding disease pathways more effectively.
"We’ve already made remarkable progress and we know that with the continued backing of our tech, AI and health experts and with the correct funding, that we can do so much more.”
John Swinney MSP, Cabinet Secretary for Finance and Sustainable Growth, oficially opened the award-winning £10.5 million Small Animal Hospital for the Faculty of Veterinary Medicine, University of Glasgow today.
Designed by Archial Architects, the Small Animal Hospital provides state of the art services for animal owners and referring practitioners throughout Scotland and Northern England, including advanced diagnostic, therapeutic and surgical techniques.
Archial's design for the Small Animal Hospital has already won a string of awards, including the prestigious RIAS Andrew Doolan Best Building in Scotland Award, a RIBA Regional Award and the Supreme Award from the Glasgow Institute of Architects.
Archial Architects has confirmed that it is to donate £2,500 from the Andrew Doolan Prize fund to the Small Animal Hospital.
Boehringer Ingelheim Vetmedica has launched a competition to find 12 dogs that have responded well to treatment with Vetmedin, to feature in the company's forthcoming 2012 Better Dogs calendar.
Boehringer is particularly interested in hearing about dogs with funny or quirky stories, or ones that have made a dramatic heart-warming recovery. If the submission makes it to the short list of 12 they will be featured in Vetmedin's 2012 Better Dogs Calendar which will be available to veterinary practices later in the year. In addition, the vet with the best story will win a £250 Red Letter Days' voucher with the 11 runners up winning the new BSAVA Manual of Thoracic Imaging.
In return for pet owners agreeing to their dog's story being submitted, Boehringer will send each veterinary practice a complimentary pack of either Vetmedin 1.25mg x 50 tablets or Vetmedin 5.0mg x 50 tablets, depending on the normal prescription, to give to their client.
Entries can be made either on the 2012 Better Dogs Calendar form which can be found in a recent Vetmedin mailing or via email to vetmedin.bra@boehringer-ingelheim.com. All entries should be accompanied by a photograph. Terms and conditions apply and the closing date for submissions is 30 September 2011.
For further information, please contact your Boehringer Ingelheim Vetmedica Territory Manager or call 01344 746959.
Three veterinary surgeons and an appointed RCVS Councillor have been awarded an OBE in the Queen's Birthday Honours.
Caroline Freedman, who has been appointed to Council from the University of Edinburgh since 2005, received a British Empire Medal for services to animal welfare in Edinburgh. Caroline will be officially retiring from Council at RCVS Day on Friday 11 July but will remain as a lay member of the Practice Standards Group - the coordinating body for the Practice Standards Scheme.
Three veterinary surgeons were also awarded OBEs in the Queen's Birthday Honours. Sarah Cleaveland, Professor of Comparative Epidemiology at the University of Glasgow, was honoured for her contribution to veterinary epidemiology. Robert Houston, former Chief Veterinary Officer for Northern Ireland, was recognised for services to veterinary science in the country and Professor Julie Fitzpatrick, the Scientific Director of the Moredun Research Institute and Chief Executive of the Moredun Foundation, was honoured for services to animal health and science.
RCVS President Colonel Neil Smith said: "I am delighted to see these very deserving people from the veterinary world receive their due recognition in this year's Birthday Honours.
"During her time on Council Caroline has provided a greatly valued lay perspective on the veterinary issues of the day and I am pleased that she will continue to give her valuable insight to the organisation through the Practice Standards Group.
"Professor Cleaveland is our guest speaker at this year's RCVS Day where she will be speaking about her vital work in tackling zoonotic diseases on an international basis, so I am delighted to see that her contribution to human and animal health is being recognised.
"In addition, Bert Houston and Professor Fitzpatrick have contributed a great deal to both the veterinary profession and animal welfare in UK, with the latter being a member of our former Research Subcommittee."
Zoetis has launched a new training programme for veterinary practices which explores every aspect of the 'client journey' - from 'pre-owner' to 'Lost' - and explains how to deliver an outstanding client experience.
The Client Experience Development Programme is divided into nine training modules which vary in length from one to five and a half hours. The whole programme can be completed in two days under the guidance of a Zoetis business consultant.
The programme breaks down each element of the client journey, from attracting new pet owners into the practice and making the right impact on new customers, to keeping long-term customers loyal.
Nick Steele, national consulting manager at Zoetis, said: "We believe that calling a practice's pet owners clients or customers is a misnomer. They are consumers because they not only purchase a practice's products and services but they also experience them and the consumer's interpretation of their experience can really affect the brand. What's more, the reality of today's information-rich environment is that consumers can experience a practice without the practice even knowing about it.
"Google have coined the term 'Zero moment of truth', which alludes to all the different points of contact a consumer can have with a product or service before physically experiencing it. The average shopper uses 10.7 different sources of information before making a decision on what product or service to use.¹ This means they may have disregarded a practice before the practice knew the consumer even existed."
The concept of the client experience is introduced with some interesting statistics which emphasise its importance. For instance, a typical business hears from only 4% of its dissatisfied customers, 96% just go away and 91% will never come back². What's more, a dissatisfied customer will tell 9-15 people about it and approximately 13% will tell more than 20 people about their problem.³
Drawing on concepts like 'The Fred Factor', which focuses on four key principles of customer care, the training programme explains how every employee can make the difference from the moment clients arrive.
Nick added: "Consumers are all powerful to veterinary practices so it is essential that the client experience is an exceptional one. Our business consultants have been trained to deliver the Client Development Programme to all types of veterinary practice to ensure that they attract as many clients to the practice as possible and keep those clients happy once they are there."
For more information about Business Consulting from Zoetis telephone 0845 519 4977 or contact your account manager.
References
Nigel Gibben said: "The Prevention Zone means anyone who keeps poultry such as chickens, ducks and geese, even as pets, must take action to stop them coming into contact with wild birds to protect them from avian flu.
"Birds should be moved into a suitable building, or if that isn’t possible owners must take sensible precautions to keep them away from wild birds, like putting up netting to create a temporary enclosure and keeping food and water supplies inside where they cannot be contaminated by wild birds.
"Even when birds are kept indoors a risk of infection remains so keepers must also practice good biosecurity, for example by disinfecting footwear and equipment and washing clothing after contact with birds.
"Recent H5N8 avian flu findings in wild birds and a backyard flock in Wales highlight just how essential it is to minimise contact between wild and captive birds and maintain good biosecurity to reduce the risk of infection.
"We must continue to be vigilant and do all we can to protect against this highly pathogenic strain of the disease, which is why we are extending the Prevention Zone, have introduced a ban on poultry gatherings and continue to strengthen surveillance to understand the extent of infection in wild birds."
The study, Urinary incontinence in bitches under primary veterinary care in England: prevalence and risk factors, which will be published in the Journal of Small Animal Practice, also found that other factors such as weight, neuter status and age also play key roles.
The authors hope that the study findings will provide an evidence base that allows veterinary surgeons to enhance their clinical recommendations for higher risk bitches.
The study was based on a population of 100,397 bitches attending 119 veterinary clinics across England. The main findings included:
The study also gave evidence on the welfare impact from urinary incontinence. Almost half of cases (45.6%) received medical therapy for the condition. In addition, of the bitches that died during the study period, urinary incontinence was recorded as either contributory or the main reason for death in 16.7 % of these deaths.
RVC veterinary epidemiologist and VetCompass researcher Dr Dan O’Neill said: "This urinary incontinence study has uncovered dramatic breed predispositions that have previously been hidden to vets and owners.
"Overall, about 3% of bitches were affected but this rose to over 30% in the Irish Setter and over 20% in the Dobermann with many other breeds also predisposed.
"Vets can now use these results to alert owners to typical clinical signs in order to ensure earlier treatment and better outcomes. The study also suggests increased risk in heavier and neutered bitches.
"Following on from this study, a VetCompass Masters project supported by BSAVA PetSavers is working to unravel these associations in order to identify potential preventive strategies, especially in those highly predisposed breeds."
The paper is available in Early View on Wiley Online Library ahead of publication in the JSAP at http://onlinelibrary.wiley.com/doi/10.1111/jsap.12731/full
Photo: ©Diane Peace Collection / The Kennel Club
Animal health specialist Fort Dodge Animal Health has announced the appointment of David Bartram BVetMed MRCVS DipM MCIM CDipAF as Technical Services Manager for Large Animals. David rejoins Fort Dodge after eight years, having previously been a Business Unit Manager for its Cydectin business. David Bartram graduated from the Royal Veterinary College in London in 1988 and, after three years in large animal practice, moved into the pharmaceutical industry where he has worked for the last 16 years. His most recent role was at Lilly, where he worked in Finance in the human sector of its pharmaceutical business. David has post graduate qualifications in marketing and finance. He replaces Susan Corning who has moved to a new role with Fort Dodge in Italy.
Congratulations to VetSurgeon members Mike Martin, Malcolm Ness and Mark Patteson, who were amongst the winners of the 2010 BSAVA Annual Awards.
Mike Martin actually collected two awards this year: The Dunkin Award for the author of the most valuable article published in the Journal of Small Animal Practice (Canine dilated cardiomyopathy: a retrospective study of signalment, presentation and clinical findings in 369 cases), and the Blaine Award presented by Royal Canin for outstanding contributions to the advancement of small animal medicine or surgery.
Malcolm Ness won the Simon Award for outstanding contributions in the field of veterinary surgery.
Mark Patteson picked up the Melton Award, presented annually by Royal Canin for meritorious contributions by veterinary surgeons to small animal veterinary practice.
Other winners included Iona Mathieson (Frank Beattie Travel Scholarship), Anne Vaughan-Thomas (deceased) (Amoroso Award), David Church (Woodrow Award), Luke Gamble (J.A. Wright Memorial Award), Olaf Reinhard Schaaf (Petsavers Award) and Steve Withrow (Bourgelat Award).
Ceva Animal Health has highlighted a new study which revealed that the use of the opioid buprenorphine, the active ingredient in Vetergesic, before equine elective general anaesthesia and surgery resulted in better post-operative analgesia than butorphanol, without causing further physiological disruption than is normally expected of general anaesthesia in horses.
The prospective, randomised and blinded multicentre study, conducted by Dr Polly Taylor VetMB MA PhD DVA DipECVAA MRCA MRCVS, an RCVS Specialist in Veterinary Anaesthesia, compared the degree of post-operative pain and physiological variables in horses following premedication with either buprenorphine or butorphanol in a general clinical setting. The study included 89 healthy adult horses from six UK equine veterinary clinics admitted for routine elective surgical procedures.
Ceva says that butorphanol is often used in equine procedures due to familiarity and its value for enhancing alpha2-induced sedation, but that it is probably the least effective opioid as an analgesic. There is also a common perception that butorphanol has less impact on locomotor stimulation and depression of intestinal motility than other opioids. This is likely to have contributed to the almost exclusive use of NSAIDs to manage pain in the post-operative period.
To view the full study, visit http://onlinelibrary.wiley.com/doi/10.1111/evj.12442/abstract. For details on Ceva's analgesic product range, email analgesics-group@ceva.com or call 01494 781510.
Sue, who is President of the European Society of Dermatology and an RCVS Specialist, says in a video interview that antimicrobial resistance (AMR) is making otitis externa cases difficult to resolve and that vets can help overcome the problem by rethinking their first line prescription choices.
In the video, created in conjunction with Elanco Animal Health (maker of Osurnia), Sue said: "It’s a sad thing to say but if everybody did manage cases of otitis externa appropriately first time, I probably wouldn’t have a job at all."
"Many of the cases I see as a referral clinician are longstanding cases with very severe, multiply-resistant infections. If we get these cases right on the first occasion with appropriate prescription of drugs, and we don’t hurt dogs so we can give ongoing treatment, then we’d never ever see pseudomonas infection again."
Sue believes part of the problem is that veterinary surgeons are incorrectly saving some of their best first-line treatments for difficult cases. This is perpetuating the antimicrobial resistance problem as cases are being inadvertently mismanaged.
She said: "Florfenicol, which is the active antibiotic in Osurnia, has excellent gram positive activity which makes it an ideal first line choice. However, there’s a misconception that florfenicol is a fluoroquinolone - which it isn’t - so vets are incorrectly ‘saving it’ rather than using it on the first occasion."
Sue also highlights that poor compliance, resulting from the patient’s behavioural problems associated with ear phobia, also has a long-term impact:
"We’ve seen many 'well behaved' dogs that have bitten their owners as a result of fear aggression; we’ve had dogs that have pinned their owners against the wall. I would argue very strongly that if you use long-acting products in dogs on the first occasion then you avoid creating that problem and these dogs don’t become difficult to medicate on a long-term basis."
Sue summarised two factors that vets need to consider when deciding on the appropriate treatment: the right active ingredients to target common first-line pathogens; and the method of application. She urged vets to consider using a long-acting product applied within the practice, removing the need for home treatment to reduce stress for both owner and the dog, improve long-term compliance and maximise clinical outcomes.
To hear Sue’s tips on how to treat cases of otitis, watch the video here – www.osurnia.co.uk
Ian (pictured right) qualified from Glasgow University and has a master’s degree in veterinary parasitology. He is head of ESCCAP - the European Scientific Counsel Companion Animal Parasites (ESCCAP) UK and Ireland, guideline director for ESCCAP Europe and editorial board member for Companion Animal. and VetCPD Journal. He is also a practising vet and co-owner of The Mount Veterinary Practice in Fleetwood, Lancashire.
Lockdown has seen a rise in the numbers of dogs and cats in the UK, including imported pets. Horiba says some of these are coming in via the official route, which includes preventative measures to reduce health risks. However, many are moved outside of UK regulations and some will become ill in the days or even months after they arrive. Ian will explain how timely, accurate testing will help detect the threat to these animals.
Lisa Martin from Horiba said: "I hope that as many veterinary surgeons, nurses, students and support staff as possible will join us for our Educational Premiere! We are looking forward to this first webinar in our veterinary CPD series, with expert Ian Wright highlighting the best ways to keep pets and people safe. Join us on 1st July at 7.30pm to hear more and to ask Ian your questions on this very topical subject. Dress code: casual."
To register, visit: https://attendee.gotowebinar.com/register/5429203015286962191
The research is being carried out by James Glass MRCVS (pictured), a PhD researcher working in the Suicide Behaviour Research Lab at the University of Glasgow, supervised by Professor Rory O'Connor - current president of the International Association for Suicide Prevention.
To take part, vets and student vets are being asked to complete a 15-25 minute survey, which must be done in one sitting.
Survey answers are strictly confidential.
Everyone is invited to participate, regardless of whether or not you have experienced suicidal thoughts, however James cautions that some of the questions may be upsetting for anyone currently experiencing suicidal feelings, and emphasises that participants are free to withdraw from the study at any point by closing the webpage, whereupon any answers already submitted with be discarded.
The study is open until 31st December 2024.
https://tinyurl.com/StudyTeamVet
The British Veterinary Association has appointed David Calpin as its new Chief Executive. David joins the BVA from Defra, where he was a Deputy Director and has held a number of senior management roles. David's policy responsibilities have included climate change, GM crops, sustainable land management, and, most recently, bovine TB. For a period last year David was Acting Director for Animal Health and Welfare in Defra.
David has been in the senior civil service since 2005, and has substantial experience of both staff and financial management. He spent two years working in Brussels representing the UK Government in EU negotiations, and has lived and worked in France, South Africa and Brazil. Prior to joining the civil service, David worked for Barclays Bank.
BVA Chairman Derek Williams said: "David's appointment comes at a very exciting time for the BVA as we respond to the challenges set out by our members in our membership research 'Your BVA, Your Say'. David has a proven track record as a senior manager, extensive experience of managing stakeholder relationships, and an excellent understanding of the political climate in the UK and Europe; all of which will ensure BVA continues to thrive and to represent members effectively."
David Calpin said: "I'm delighted to be joining the BVA. I've worked closely with the BVA in my previous roles and have been hugely impressed. I also know that no organisation can afford to stand still, and that the BVA needs to keep pace with changes in the veterinary profession.
"I'm really looking forward to the challenge of leading the BVA through a period of change to become an even more effective voice for the profession and providing services that members value. I have a lot to learn and I'm keen to get out and about to meet as many people as possible and to hear first-hand what the profession wants from the BVA."
The Westpoint Group has announced the divestiture of its small animal and equine veterinary practices in order to focus on production animal health and welfare.
From now, the production animal business - which includes veterinary practices providing services to pig, poultry, dairy, beef, sheep, game bird producers and small holders - will be known under the umbrella brand of Origin.
The company says that excellence and innovation in client service will continue to be the focus throughout the organisation.
Matt Dobbs, Managing Director of Origin said: "Origin is committed to supporting livestock farmers to enhance production by improving health and welfare. We have a unique group of vets, researchers, lab techs and paraprofessionals passionate about the success of UK agriculture, with other businesses committed to supporting the industry, joining us through the autumn.
"By focusing on supporting farmers, we will become a unique source of animal insight in livestock agriculture."
For more information, visit: http://www.westpointveterinarygroup.com
Annual renewal fees for veterinary surgeons will remain at the same level as in 2021: £364 for UK-practising members, £182 for members practising outside the UK and £60 for non-practising members.
The removal of the alternative fee payment arrangements means there will no longer be the option to pay in instalments and the fee needs to be paid in full by the usual deadline of 1 April.
RCVS Treasurer Niall Connell said: “We understand that many veterinary surgeons and veterinary nurses will have been impacted financially over the last couple of years, and we appreciate that this has been a very difficult time for the professions.
"We are pleased that we are able to keep fees static for a second year running, whilst maintaining a strong programme of strategic projects that help to set, uphold and advance standards within the professions.”
The British Veterinary Association's Council has agreed unanimously to reject Animal Health's proposal to base fees for Official Veterinarians (OVs) on the available budget instead of an hourly rate, which the BVA negotiating team has been pushing for for some time.
The BVA team argued consistently for a professional fee for professional work and based its demands on the independent ADAS report and SPVS fees surveys. Animal Health proposed a matrix for TB testing fees based on the number of animals tested and the distance travelled and said that there would be no further discussion on an appropriate professional fee due to budget constraints. The BVA Council felt strongly that it could not accept a proposal that was based on a finite budget and did not respect the need for a professional fee for veterinary work.
BVA President Bill Reilly said: "While we understand the budget squeeze on Animal Health, BVA Council has taken a principled stand that vets should be paid a professional fee for a professional service, not a fee based on the available budget.
"With the launch of the draft Animal Health Bill last Monday we call on the Government to consider the central role OVs play in this new disease control set up and to provide sufficient funding. Launching the draft Bill, Defra's Minister of State spoke of partnership. OVs are such a partner, professionals integral to the disease prevention and control mechanisms. The country has a major disease problem in TB which requires professionals to ensure control and protection of the public and animals alike.
"Let me clarify that Animal Health will not be negotiating with individual vets - they will simply be paying at the same rate in 2010/11 as in 2009/10 and no guarantee that the budget will not be reduced in the future. Each individual veterinary practice will need to decide whether or not they wish to continue TB testing or other OV work."
The BVA and BCVA are advising members that they will need to take a decision in their own practice on whether or not it is financially viable for them to continue OV work.
Horiba Medical has announced it is the official exclusive UK distributor of the fully automated Vet abc Plus+ veterinary haematology analyser from scil animal care company GmbH, Germany.
According to the company, the compact Vet abc Plus+ provides a complete blood count (CBC), including 4-part white blood cell (WBC) differential, from only 10 µl of EDTA whole blood, in only 60 seconds.
The Vet abc Plus+ provides pre-installed settings to analyse samples from dogs, cats, horses, rabbits, mice, rats, cattle, pigs and sheep. For dogs, cats and horses, the Vet abc Plus+ provides a 4-part WBC differential blood count, including a differentiation of the leucocytes to identify lymphocytes, monocytes, granulocytes and eosinophils. Results are available in 60 seconds on screen or can be automatically printed out and transferred to the practice information system or clinical notes. For ease-of-use, the Vet abc Plus+ also incorporates a self-contained reagent and waste system which provides a clean operation whilst being easy to replenish.
Borne from an existing manufacturing partnership, scil and HORIBA Medical already have over 6000 veterinary haematology analysers placed globally. Horiba says the new UK distribution agreement enables UK veterinary professionals to not only procure the Vet abc Plus+ analyser, but also receive expert service and support directly from the manufacturer HORIBA Medical and its team of UK specialists.
For more information, visit: www.horiba.com/uk/medical